JPET Highlight: Lyn kinase activator MLR-1023 potentiates insulin and improves glucose homeostasis
Posted on 1/1/0001 12:00:00 AM
|
Tags:
MLR-1023 lowered blood glucose similar to metformin without eliciting a hypoglycemic response, with a faster onset of action than roziglitazone and without causing weight gain. See article atJ Pharmacol Exp Ther 2012, 342:23-32. (JPET 192187)
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics